Myocardial Fibrosis

Views 259
Jump to
Abstracts Focused Research Topics
Your Token Count0

Sign in to Purchase/Download Documents

Sign in / Register

Focus Your Research

Click any topic below to filter + focus research
6 Substances Researched for Myocardial Fibrosis
NameACCKFocus
Curcumin47Locked
Berberine12Locked
EGCG (Epigallocatechin gallate)12Locked
Probiotics12Locked
Puerarin12Locked
Rosmarinic acid12Locked

View the Evidence:
37 Abstracts with Myocardial Fibrosis Research

[+]

There was less fibrosis in elderly subjects supplemented with selenium and coenzyme Q10.Dec 07, 2017

Pubmed Data : Biofactors. 2017 Dec 8. Epub 2017 Dec 8. PMID: 29220105
Article Published Date : Dec 07, 2017
Study Type : Human Study
Additional Links
Substances : Coenzyme Q10, Selenium
Diseases : Cardiac Mortality , Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective
Additional Keywords : Risk Reduction
[+]

Astaxanthin may be useful as a preventive/therapeutic agent for cardiac dysfunction and myocardial fibrosis.Mar 11, 2017

Pubmed Data : Biochim Biophys Acta. 2017 Mar 12. Epub 2017 Mar 12. PMID: 28300638
Article Published Date : Mar 11, 2017
Study Type : Human In Vitro
Additional Links
Substances : Astaxanthin
Diseases : Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective
[+]

Cinnamaldehyde may be able to slow down the progression of cardiac fibrosis.Mar 20, 2017

Pubmed Data : Zhonghua Yi Xue Za Zhi. 2017 Mar 21 ;97(11):869-873. PMID: 28355745
Article Published Date : Mar 20, 2017
Study Type : Human In Vitro
Additional Links
Substances : Cinnamaldehyde
Diseases : Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic
[+]

Asiatic acid attenuates pressure overload-induced cardiac fibrosis.Jun 25, 2019

Pubmed Data : Int Immunopharmacol. 2019 Jun 26 ;74:105712. Epub 2019 Jun 26. PMID: 31254954
Article Published Date : Jun 25, 2019
Study Type : Animal Study
Additional Links
Substances : Asiatic Acid
Diseases : Hypertension, Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Antioxidants, Cardioprotective, Heme oxygenase-1 up-regulation, Nrf2 activation
[+]

AstragalosideⅣ was beneficial against cardiac fibrosis.Jun 30, 2017

Pubmed Data : Phytomedicine. 2017 Jul 1 ;30:10-17. Epub 2017 Apr 19. PMID: 28545665
Article Published Date : Jun 30, 2017
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : Astragaloside
Diseases : Hypoxia, Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective
[+]

Berberine might become a new strategy for treating cardiac fibrosis in the future.Dec 31, 2014

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Int J Clin Exp Pathol. 2015 ;8(10):12509-16. Epub 2015 Oct 1. PMID: 26722438
Article Published Date : Dec 31, 2014
Study Type : Animal Study
Additional Links
Substances : Berberine
Diseases : Myocardial Fibrosis
Pharmacological Actions : Cardioprotective
[+]

Curcumin attenuates cardiac fibrosis in spontaneously hypertensive rats through PPAR-γ activation.Sep 30, 2014

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Acta Pharmacol Sin. 2014 Oct ;35(10):1247-56. Epub 2014 Aug 18. PMID: 25132338
Article Published Date : Sep 30, 2014
Study Type : Animal Study
Additional Links
Substances : Curcumin
Diseases : Hypertension, Myocardial Fibrosis , Myocardial Infarction
Pharmacological Actions : Antihypertensive Agents, Cardioprotective
[+]

Curcumin may have therapeutic value in treating aortic stenosis, left ventricular dysfunction and myocardial fibrosis. Mar 01, 2009

Pubmed Data : Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Mar;37(3):262-7. PMID: 19781154
Article Published Date : Mar 01, 2009
Study Type : Animal Study
Additional Links
Substances : Curcumin
Diseases : Aortic Stenosis, Left Ventricular Hypertrophy, Myocardial Fibrosis
[+]

Curcumin protects against myocardial infarction-induced cardiac fibrosis.Dec 31, 2015

Pubmed Data : Drug Des Devel Ther. 2016 ;10:1267-77. Epub 2016 Mar 29. PMID: 27099472
Article Published Date : Dec 31, 2015
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : Curcumin
Diseases : Myocardial Fibrosis , Myocardial Infarction
Pharmacological Actions : Cardioprotective, SIRT1 Activator
[+]

Epigallocatechin-3-O-gallate attenuated the endoglin expression and myocardial fibrosis in vitro and in vivo.Jun 15, 2016

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : J Cell Mol Med. 2016 Jun 16. Epub 2016 Jun 16. PMID: 27306149
Article Published Date : Jun 15, 2016
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : EGCG (Epigallocatechin gallate)
Diseases : Myocardial Fibrosis
Pharmacological Actions : Anti-Inflammatory Agents, Cardioprotective
[+]

Fucoidan and fucoxanthin in combination can potentially reduce cardiac hypertrophy, cardiac fibrosis, ROS level,Jan 20, 2019

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Mar Drugs. 2019 Jan 21 ;17(1). Epub 2019 Jan 21. PMID: 30669571
Article Published Date : Jan 20, 2019
Study Type : Animal Study
Additional Links
Substances : Fucoidan, Fucoxanthin
Diseases : Aging: Heart, Cardiac Hypertrophy, Myocardial Fibrosis
Pharmacological Actions : Antioxidants, Cardioprotective
[+]

Gallic acid has therapeutic potential for the treatment of heart failure-induced pulmonary fibrosis.Nov 30, 2017

Pubmed Data : Vascul Pharmacol. 2017 Dec ;99:74-82. Epub 2017 Oct 31. PMID: 29097327
Article Published Date : Nov 30, 2017
Study Type : Animal Study
Additional Links
Substances : Gallic Acid
Diseases : Heart Failure, Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic
[+]

Gastrodin protects against cardiac hypertrophy and fibrosis.Dec 31, 2011

Pubmed Data : Mol Cell Biochem. 2012 Jan ;359(1-2):9-16. Epub 2011 Jul 16. PMID: 21833534
Article Published Date : Dec 31, 2011
Study Type : Animal Study
Additional Links
Substances : Gastrodin
Diseases : Cardiac Hypertrophy, Myocardial Fibrosis
Pharmacological Actions : Cardioprotective
[+]

Ginsenoside Rh2 is suitable to develop as an alternative remedy for cardiac fibrosis.Jun 25, 2017

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Int J Mol Sci. 2017 Jun 26 ;18(7). Epub 2017 Jun 26. PMID: 28672855
Article Published Date : Jun 25, 2017
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : Ginsenosides
Diseases : Diabetes Mellitus: Type 1, Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective
[+]

Neferine may have antifibrogenic effects in diabetes-related cardiac fibrosis.Sep 19, 2016

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Oncotarget. 2016 Sep 20 ;7(38):61703-61715. PMID: 27533252
Article Published Date : Sep 19, 2016
Study Type : Animal Study
Additional Links
Substances : Lotus
Diseases : Diabetic Complications, Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective
Additional Keywords : Anti-Fibrotic, Cardioprotective, Diabetic Complications, Lotus, Myocardial Fibrosis
[+]

Nrf2 Is a key regulator on puerarin preventing cardiac fibrosis.Dec 31, 2017

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Pharmacol. 2018 ;9:540. Epub 2018 Jun 6. PMID: 29928229
Article Published Date : Dec 31, 2017
Study Type : Animal Study
Additional Links
Substances : Puerarin
Diseases : Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective
[+]

Oral administration of probiotics may attenuate cardiomyocyte fibrosis and cardiac hypertrophy.Dec 31, 2015

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Int J Med Sci. 2016 ;13(4):277-85. Epub 2016 Mar 30. PMID: 27076784
Article Published Date : Dec 31, 2015
Study Type : Animal Study
Additional Links
Substances : Probiotics
Diseases : High Fat Diet, Myocardial Fibrosis
Pharmacological Actions : Autophagy Up-regulation, Cardioprotective
[+]

Paeoniflorin improves pressure overload-induced cardiac remodelling by modulating the MAPK signalling pathway in spontaneously hypertensive rats.Feb 28, 2019

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Biomed Pharmacother. 2019 Mar ;111:695-704. Epub 2019 Jan 3. PMID: 30611994
Article Published Date : Feb 28, 2019
Study Type : Animal Study
Additional Links
Substances : Paeoniflorin
Diseases : Cardiac Hypertrophy, Inflammation, Myocardial Fibrosis
Pharmacological Actions : Anti-Inflammatory Agents, Cardioprotective, Interleukin-6 Downregulation
[+]

Piperine attenuated cardiac fibrosis in mice.Mar 31, 2017

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : EBioMedicine. 2017 Apr ;18:179-187. Epub 2017 Mar 14. PMID: 28330809
Article Published Date : Mar 31, 2017
Study Type : Animal Study
Additional Links
Substances : Piperine
Diseases : Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective
[+]

Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosisAug 14, 2018

Pubmed Data : Eur J Pharmacol. 2018 Aug 15 ;833:545-554. Epub 2018 Jun 18. PMID: 29913124
Article Published Date : Aug 14, 2018
Study Type : Animal Study
Additional Links
Substances : Astragaloside
Diseases : Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective
[+]

Puerarin could be a potential agent in attenuating myocardial Infarction induced cardiac fibrosis.Dec 31, 2015

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Am J Transl Res. 2016 ;8(10):4425-4433. Epub 2016 Oct 15. PMID: 27830026
Article Published Date : Dec 31, 2015
Study Type : Animal Study
Additional Links
Substances : Puerarin
Diseases : Myocardial Fibrosis , Myocardial Infarction
Pharmacological Actions : Anti-Fibrotic
[+]

Puerarin may provide a new adjuvant for antifibrotic treatment strategies for patients with heart disease.Dec 31, 2016

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : PPAR Res. 2017 ;2017:2647129. Epub 2017 May 30. PMID: 28638404
Article Published Date : Dec 31, 2016
Study Type : Animal Study
Additional Links
Substances : Puerarin
Diseases : Heart Disease, Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective
[+]

Rosmarinic acid can protect against cardiac dysfunction and fibrosis following myocardial infarction.Aug 18, 2016

Pubmed Data : J Agric Food Chem. 2016 Aug 19. Epub 2016 Aug 19. PMID: 27538767
Article Published Date : Aug 18, 2016
Study Type : Animal Study
Additional Links
Substances : Rosmarinic acid
Diseases : Myocardial Fibrosis , Myocardial Infarction
Pharmacological Actions : Cardioprotective
[+]

Rosmarinic acid might be a promising therapeutic agent against cardiac fibrosis.Jan 23, 2018

Pubmed Data : Cell Death Dis. 2018 Jan 24 ;9(2):102. Epub 2018 Jan 24. PMID: 29367637
Article Published Date : Jan 23, 2018
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : Rosmarinic acid
Diseases : Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective
[+]

Tanshinone IIA exerts antifibrotic effects in postinfarct cardiac fibrosis.Apr 30, 2015

Pubmed Data : J Cardiovasc Pharmacol. 2015 May ;65(5):456-64. PMID: 25636075
Article Published Date : Apr 30, 2015
Study Type : Animal Study
Additional Links
Substances : Tanshinone IIA
Diseases : Myocardial Fibrosis , Myocardial Infarction
Pharmacological Actions : Anti-Fibrotic, MicroRNA modulator
[+]

Tanshinone IIA protects against subclinical lipopolysaccharide induced cardiac fibrosis.Jun 30, 2018

Pubmed Data : Int Immunopharmacol. 2018 Jul ;60:59-63. Epub 2018 Apr 25. PMID: 29704740
Article Published Date : Jun 30, 2018
Study Type : Animal Study
Additional Links
Substances : Tanshinone IIA
Diseases : Lipopolysaccharide-Induced Toxicity, Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective
[+]

These results suggested that puerarin could prevent isoprenaline-induced myocardial fibrosis.Aug 31, 2012

Pubmed Data : J Nutr Biochem. 2012 Sep ;23(9):1080-5. Epub 2011 Nov 12. PMID: 22079205
Article Published Date : Aug 31, 2012
Study Type : Animal Study
Additional Links
Substances : Puerarin
Diseases : Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective, NF-kappaB Inhibitor
[+]

Thymoquinone prevents myocardial and perivascular fibrosis induced by chronic lipopolysaccharide exposure.Nov 30, 2018

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : J Pharmacopuncture. 2018 Dec ;21(4):284-293. Epub 2018 Dec 31. PMID: 30652055
Article Published Date : Nov 30, 2018
Study Type : Animal Study
Additional Links
Substances : Thymoquinone
Diseases : Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Anti-Inflammatory Agents, Antioxidants, Cardioprotective
[+]

Treatment by Nigella sativa reduced myocardial fibrosis in inflammation-induced fibrosis.Jan 31, 2017

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Res Pharm Sci. 2017 Feb ;12(1):74-81. PMID: 28255317
Article Published Date : Jan 31, 2017
Study Type : Animal Study
Additional Links
Substances : Nigella sativa (aka Black Seed)
Diseases : Inflammation, Lipopolysaccharide-Induced Toxicity, Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic
Additional Keywords : Anti-Fibrotic, Inflammation, Lipopolysaccharide-Induced Toxicity, Myocardial Fibrosis, Nigella sativa (aka Black Seed)
[+]

Ursolic acid has an anti-fibrotic effect and attenuates the mitochondrial and lysosomal dysfunction in Isoproterenol-induced myocardial infarction.Apr 11, 2019

Pubmed Data : Hum Exp Toxicol. 2019 Apr 12:960327119842620. Epub 2019 Apr 12. PMID: 30977399
Article Published Date : Apr 11, 2019
Study Type : Animal Study
Additional Links
Substances : Ursolic Acid
Diseases : Myocardial Fibrosis , Myocardial Infarction
Pharmacological Actions : Anti-Fibrotic, Cardioprotective
[+]

Betulinic acid may offer therapeutic potential towards the treatment of cardiac fibrosis.Oct 31, 2017

Pubmed Data : Mol Med Rep. 2017 Nov ;16(5):6320-6325. Epub 2017 Aug 22. PMID: 28849070
Article Published Date : Oct 31, 2017
Study Type : In Vitro Study
Additional Links
Substances : Betulinic acid
Diseases : Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective
[+]

Curcumin may be a potential therapeutic agent for the treatment of cardiac fibrosis.Feb 29, 2016

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Exp Ther Med. 2016 Mar ;11(3):998-1004. Epub 2016 Jan 8. PMID: 26998027
Article Published Date : Feb 29, 2016
Study Type : In Vitro Study
Additional Links
Substances : Curcumin
Diseases : Myocardial Fibrosis
Pharmacological Actions : Cardioprotective
[+]

Evodiamine prevents isoproterenol-induced cardiac fibrosis.May 31, 2017

Pubmed Data : Planta Med. 2017 Jun ;83(9):761-769. Epub 2016 Dec 23. PMID: 28010025
Article Published Date : May 31, 2017
Study Type : In Vitro Study
Additional Links
Substances : Evodiamine
Diseases : Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective
Problem Substances : Isoproterenol
[+]

Naringenin may become a novel strategy for treating cardiac fibrosis.Oct 31, 2017

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Exp Ther Med. 2017 Nov ;14(5):4425-4430. Epub 2017 Sep 5. PMID: 29104653
Article Published Date : Oct 31, 2017
Study Type : In Vitro Study
Additional Links
Substances : Naringenin
Diseases : Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective, Transforming growth factor beta (TGF-β) inhibitor
[+]

Piperlongumine inhibits angiotensin II-induced extracellular matrix expression in cardiac fibroblasts.Nov 30, 2018

Pubmed Data : J Cell Biochem. 2018 Dec ;119(12):10358-10364. Epub 2018 Aug 26. PMID: 30145839
Article Published Date : Nov 30, 2018
Study Type : In Vitro Study
Additional Links
Substances : Piperlongumine
Diseases : Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective
[+]

Tanshinone IIA could be beneficial in the treating diabetic-related cardiac fibrosis.Dec 31, 2017

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Cell Physiol Biochem. 2018 ;51(5):2250-2261. Epub 2018 Dec 7. PMID: 30537733
Article Published Date : Dec 31, 2017
Study Type : In Vitro Study
Additional Links
Substances : Tanshinone IIA
Diseases : Diabetic Complications, Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Antioxidants, Nrf2 activation
[+]

Tanshinone IIA protects against cardiac fibrosis through inhibition of β-tubulin expression.Oct 31, 2018

Pubmed Data : J Biol Regul Homeost Agents. 2018 Nov-Dec;32(6):1451-1455. PMID: 30574749
Article Published Date : Oct 31, 2018
Study Type : In Vitro Study
Additional Links
Substances : Tanshinone IIA
Diseases : Myocardial Fibrosis
Pharmacological Actions : Anti-Fibrotic, Cardioprotective

Copyright: pablofdezr / 123RF Stock Photo

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2019 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.